78 related articles for article (PubMed ID: 619323)
1. Estrogen excretion patterns in induced ovulation.
Biggs JS; Hennessey J; Jones I
Obstet Gynecol; 1978 Jan; 51(1):10-5. PubMed ID: 619323
[TBL] [Abstract][Full Text] [Related]
2. Use of ultrasound in monitoring ovulation induction with human pituitary gonadotropins.
O'Herlihy C; Evans JH; Brown JB; de Crespigny LJ; Robinson HP
Obstet Gynecol; 1982 Nov; 60(5):577-82. PubMed ID: 7145249
[TBL] [Abstract][Full Text] [Related]
3. Incremental clomiphene therapy: a new method for treating persistent anovulation.
O'Herlihy C; Pepperell RJ; Brown JB; Smith MA; Sandri L; McBain JC
Obstet Gynecol; 1981 Nov; 58(5):535-42. PubMed ID: 6795551
[TBL] [Abstract][Full Text] [Related]
4. Analysis of variables in treatment of anovulation with human gonadotrophins.
Bertrand PV; Butt WR; Crooke AC; Sutaria UD
Endocrinol Exp; 1976; 10(4):271-81. PubMed ID: 1087228
[TBL] [Abstract][Full Text] [Related]
5. An unexpectedly high rate of ectopic pregnancy following the induction of ovulation with human pituitary and chorionic gonadotrophin.
McBain JC; Evans JH; Pepperell RJ; Robinson HP; Smith MA; Brown JB
Br J Obstet Gynaecol; 1980 Jan; 87(1):5-9. PubMed ID: 7362790
[TBL] [Abstract][Full Text] [Related]
6. [Clinical application of the gonadotropin--ovulation induction].
Fukui A; Kimura H; Fujii S; Mizunuma H
Nihon Rinsho; 2006 Apr; 64 Suppl 4():230-6. PubMed ID: 16689314
[No Abstract] [Full Text] [Related]
7. Luteal phase hyperprolactinemia during ovulation induction with human menopausal gonadotropins: incidence, recurrence, and effect on pregnancy rates.
Tippet PD; Simon JA; Rifka SM; Falk RJ
Obstet Gynecol; 1989 Apr; 73(4):613-6. PubMed ID: 2494621
[TBL] [Abstract][Full Text] [Related]
8. Experience with the induction of ovulation.
Gemzell CA
J Reprod Med; 1978 Sep; 21(3 Suppl):205-7. PubMed ID: 722709
[No Abstract] [Full Text] [Related]
9. Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin.
Tulandi T; McInnes RA; Arronet GH
Int J Fertil; 1984; 29(2):113-7. PubMed ID: 6148315
[TBL] [Abstract][Full Text] [Related]
10. Late infertile days in early postpartum cycles.
Hatherley LI
Clin Reprod Fertil; 1985 Mar; 3(1):73-80. PubMed ID: 4038908
[TBL] [Abstract][Full Text] [Related]
11. Results of human menopausal gonadotropin therapy at the Boston Hospital for Women (1979-1981).
Jones KP; Ravnikar VA; Schiff I
Int J Fertil; 1987; 32(2):131-4. PubMed ID: 2883138
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of ovulation induction with HMG-HCG therapy by plasma estrogen and progesterone.
Muechler EK; Kohler D; Huang KE
Int J Fertil; 1981; 26(4):273-8. PubMed ID: 6120908
[TBL] [Abstract][Full Text] [Related]
13. Ovulation induction with human menopausal gonadotropins.
Diamond MP; Wentz AC
Obstet Gynecol Surv; 1986 Aug; 41(8):480-90. PubMed ID: 3090489
[TBL] [Abstract][Full Text] [Related]
14. [Ovulation induction using gonadotropins].
Bettendorf G; Breckwoldt M; Lehmann F
Zentralbl Gynakol; 1972 Dec; 94(49):1687-96. PubMed ID: 4650318
[No Abstract] [Full Text] [Related]
15. Addition of human chorionic gonadotropin to clomiphene citrate ovulation induction therapy does not improve pregnancy outcomes and luteal function.
Yilmaz B; Kelekci S; Savan K; Oral H; Mollamahmutoglu L
Fertil Steril; 2006 Mar; 85(3):783-6. PubMed ID: 16500364
[TBL] [Abstract][Full Text] [Related]
16. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
[TBL] [Abstract][Full Text] [Related]
17. Experience with combined individualized method of hMG/hCG therapy.
Samberg I; Tal J; Zilberman A; Oettinger M; Sharf M
Int J Fertil; 1983; 28(2):85-90. PubMed ID: 6136481
[TBL] [Abstract][Full Text] [Related]
18. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
Notation AD; Tagatz GE; Steffes MW
Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
20. Use of exogenous gonadotropins in anovulatory women: a technical bulletin.
Practice Committee of American Society for Reproductive Medicine
Fertil Steril; 2008 Nov; 90(5 Suppl):S7-12. PubMed ID: 19007651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
